'High proliferative cribriform prostate cancer' defines a patient subgroup with an inferior prognosis.

Bogaard, Mari; Skotheim, Rolf I; Maltau, Aase V; Kidd, Susanne G; Lothe, Ragnhild A; Axcrona, Karol; Axcrona, Ulrika

Bogaard, Mari; Skotheim, Rolf I; Maltau, Aase V; Kidd, Susanne G; Lothe, Ragnhild A; Axcrona, Karol; Axcrona, Ulrika.

Afiliación

Bogaard M; Department of Pathology, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.
Skotheim RI; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.
Maltau AV; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Kidd SG; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.
Lothe RA; Department of Informatics, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.
Axcrona K; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.
Axcrona U; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.

Histopathology ; 83(6): 853-869, 2023 Dec.

Article en En | MEDLINE | ID: mdl-37501635

Asunto(s)

Biomarcadores de Tumor; Neoplasias de la Próstata; Masculino; Humanos; Antígeno Ki-67; Biomarcadores de Tumor/metabolismo; Pronóstico; Neoplasias de la Próstata/patología; Próstata/patología; Prostatectomía/métodos; Clasificación del Tumor

Palabras clave

ERG; Ki67; PTEN; biomarker; cribriform pattern; prognosis; prostate cancer; reactive stroma

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Biomarcadores de Tumor Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Histopathology Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google